American University of Beirut Medical Center

aub.edu.lb

Total trials

155

Active

26

Phase 3

17

Total enrollment

104,012

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Ascorbic Acid 1000 MG3
Adalimumab1
Glofitamab1
Chemotherapy + Immunotherapy Induction1
Immunotherapy Maintenance1
Diltiazem1
Mebo1
Naproxen1
Esomeprazole 20mg once daily1
propofol2
Paravertebral block1
Erector Spinae block1
Metformin Hcl 850Mg Tab1

Next readouts

  • 2025-11
  • 2025-12
  • 2026-01-01
  • 2026-08-15
  • 2026-09-15
  • 2028-05-01
  • 2028-08
  • 2029-04
  • 2031-12-15

Top conditions

  • Obesity7
  • Anesthesia5
  • Sterility4
  • Infertility4
  • Weight Loss4
  • Childhood Obesity3
  • Diabetes3
  • Amyotrophic Lateral Sclerosis3

Frequently asked questions about American University of Beirut Medical Center

How many clinical trials does American University of Beirut Medical Center have on ClinicalTrials.gov?
American University of Beirut Medical Center is listed as the lead sponsor on 155 clinical trials in ClinicalTrials.gov, 26 of which are currently active (recruiting, enrolling, or ongoing).
How many of American University of Beirut Medical Center's trials are in Phase 3?
17 of American University of Beirut Medical Center's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does American University of Beirut Medical Center focus on?
American University of Beirut Medical Center's most-studied conditions on ClinicalTrials.gov are Obesity, Anesthesia, Sterility, Infertility, Weight Loss.
When are American University of Beirut Medical Center's next clinical trial readouts?
American University of Beirut Medical Center has 9 upcoming primary-completion readouts tracked here; the soonest is “Effect of Discontinuing Propofol After Cecal Intubation on Patient's Psychomotor Recovery Following Colonoscopy”, expected around 2025-11.